You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 18, May 9, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Gastroenterology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Leukemias/ Lymphomas
 •Immunology
 •Immunologic Disorders
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risk of Non-Hodgkin Lymphoma and Lymphoproliferative Precursor Diseases in US Veterans With Hepatitis C Virus

Thomas P. Giordano, MD, MPH; Louise Henderson, MSPH, PhD; Ola Landgren, MD, PhD; Elizabeth Y. Chiao, MD, MPH; Jennifer R. Kramer, PhD, MPH; Hashem El-Serag, MD, MPH; Eric A. Engels, MD, MPH

JAMA. 2007;297(18):2010-2017.

Context  Hepatitis C virus (HCV) infection causes liver cancer and cirrhosis and may also increase the risk of other tumors, particularly hematopoietic malignancies and thyroid cancer. Previous studies have been too small to adequately assess these risks.

Objective  To test the hypothesis that HCV infection is associated with increased risk for hematological malignancies, related lymphoproliferative disorders, and thyroid cancer.

Design, Setting, and Patients  A retrospective cohort study of users of US Veterans Affairs health care facilities from 1997-2004, which included 146 394 patients infected with HCV who had at least 2 visits with a diagnostic code for HCV infection, and 572 293 patients uninfected with HCV. To assemble the HCV-uninfected cohort, we randomly selected up to 4 patients per patient infected with HCV from all veterans who matched on age, sex, and baseline visit date and type (inpatient or outpatient). Individuals with human immunodeficiency virus were excluded.

Main Outcome Measures  Risks of hematopoietic malignancies, related lymphoproliferative precursor diseases, and thyroid cancer, adjusting for selection factors, race, era of military service, and use of medical services.

Results  The mean (SD) age of the patients was 52 (8) years, and 97% were men. Risks for non-Hodgkin lymphoma (n = 1359), Waldenström macroglobulinemia (n = 165), and cryoglobulinemia (n = 551) were increased with HCV infection (adjusted hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.12-1.45; adjusted HR, 2.76; 95% CI, 2.01-3.79; and adjusted HR, 3.98; 95% CI, 3.36-4.72; respectively). We found no significantly increased risk for other hematological malignancies. Although thyroiditis risk was slightly increased, risk for thyroid cancer (n = 320) was not (adjusted HR, 0.72; 95% CI, 0.52-0.99). Adjusted P values for non-Hodgkin lymphoma, Waldenström macroglobulinemia, cryoglobulinemia, and thyroiditis were all <.0038, the Bonferroni threshold for statistical significance considering multiple comparisons.

Conclusions  Hepatitis C virus infection confers a 20% to 30% increased risk of non-Hodgkin lymphoma overall, and a 3-fold higher risk of Waldenström macroglobulinemia, a low-grade lymphoma. Risks were also increased for cryoglobulinemia. These results support an etiological role for HCV in causing lymphoproliferation and causing non-Hodgkin lymphoma.


Author Affiliations: Department of Medicine, Baylor College of Medicine, and the Houston Center for Quality of Care and Utilization Studies, Health Services Research and Development Service, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Tex (Drs Giordano, Henderson, Chiao, Kramer, and El-Serag); and the National Cancer Institute, National Institutes of Health, Rockville, Md (Drs Landgren and Engels).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Prevalence of Type 1 Gaucher Disease in the United States--Reply
, , , and
Arch Intern Med. ;168():327-328.
FULL TEXT  

RELATED ARTICLE

Lymphoma
, , and
JAMA. ;297():2044-2044.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies
Kristinsson et al.
haematol 2009;94:1581-1589.
ABSTRACT | FULL TEXT  

Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin
Coffey et al.
J. Cell Sci. 2009;122:3137-3144.
ABSTRACT | FULL TEXT  

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
Landgren et al.
Blood 2009;114:791-795.
ABSTRACT | FULL TEXT  

The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders
Landau et al.
Ann Rheum Dis 2009;68:337-344.
ABSTRACT | FULL TEXT  

Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection
Chiao et al.
Arch Intern Med 2009;169:357-363.
ABSTRACT | FULL TEXT  

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Ramos et al.
haematol 2009;94:249-257.
ABSTRACT | FULL TEXT  

The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma
Evens and Chiu
JAMA 2008;300:2059-2061.
FULL TEXT  

Hematopoietic Malignancies Associated with Viral and Alcoholic Hepatitis
Anderson et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:3069-3075.
ABSTRACT | FULL TEXT  

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden
Kristinsson et al.
Blood 2008;112:3052-3056.
ABSTRACT | FULL TEXT  

Chronic Immune Stimulation and Subsequent Waldenstrom Macroglobulinemia
Koshiol et al.
Arch Intern Med 2008;168:1903-1909.
ABSTRACT | FULL TEXT  

Understanding Microbe-Induced Cancers
Blaser
Cancer Prevention Research 2008;1:15-20.
ABSTRACT | FULL TEXT  

Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders
Brown et al.
Blood 2008;111:3388-3394.
ABSTRACT | FULL TEXT  

Prevalence of Type 1 Gaucher Disease in the United States--Reply
Landgren et al.
Arch Intern Med 2008;168:327-328.
FULL TEXT  

Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
Charles et al.
Blood 2008;111:1344-1356.
ABSTRACT | FULL TEXT  

Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients
Morton et al.
Blood 2007;110:4599-4605.
ABSTRACT | FULL TEXT  

Hepatitis C virus and lymphoma
Viswanatha and Dogan
J. Clin. Pathol. 2007;60:1378-1383.
ABSTRACT | FULL TEXT  

Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana
Landgren et al.
Mayo Clin Proc. 2007;82:1468-1473.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.